rewirebio.iobenchmarks
Result

Count (rank: top 10) of Exomiser v14 default, Talos 2026 comparison on ACG trios: Exomiser SNV/indel comparison as reported in Results

164 Count (rank: top 10)

Methods

Tested configuration
Exomiser v14 default, Talos 2026 comparison
Protocol
Exomiser rank-budget recovery in ACG trios
Dataset
ACG trios: Exomiser SNV/indel comparison as reported in Results
Related family profiles
Exomiser
Evaluation
Exomiser v14 ACG trio rank-budget evaluation
Coverage
Not reported scored / Not reported eligible
Uncertainty
Not reported by the source: not reported for this endpoint
Evidence
Author-reported evaluation · source checkedAutomated reanalysis of genomic data for rare disease diagnostics at scale · Results, Comparison with other tools, rank top10

A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.

Reproduction

Split
Not reported
Adaptation
Not reported
Scoring implementation
Source-defined endpoint; see result source_locator

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Reported result
164
Individual claims
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

Results, Comparison with other tools, rank top10

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

source checked

["automated-source-review"] · 2026-09-30

author reported

Audit details

Transcription from inspected primary source. No execution, independent replication or human scientific review.

Field: attributes.printed_value

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20260930-exomiser-top10-count

areas
dna-genomes
contexts
clinical_research
metric
count
unit
count
printed value
164
numeric value
164
metric direction
unknown
source locator
Results, Comparison with other tools, rank top10
review
method: automated-source-review; reviewer: codex; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-talos; reviewer note: role: clinical coverage worker
denominator
194
missing metadata
uncertainty: reason: unreported; note: not reported for this endpoint
metric qualifier
rank: top 10
Related records

Suggest a correction